12-10408358-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_013431.2(KLRC4):ā€‹c.311A>Gā€‹(p.Asn104Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.649 in 1,466,520 control chromosomes in the GnomAD database, including 313,016 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.

Frequency

Genomes: š‘“ 0.61 ( 28937 hom., cov: 31)
Exomes š‘“: 0.65 ( 284079 hom. )

Consequence

KLRC4
NM_013431.2 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.06
Variant links:
Genes affected
KLRC4 (HGNC:6377): (killer cell lectin like receptor C4) Natural killer (NK) cells are lymphocytes that can mediate lysis of certain tumor cells and virus-infected cells without previous activation. They can also regulate specific humoral and cell-mediated immunity. NK cells preferentially express several calcium-dependent (C-type) lectins, which have been implicated in the regulation of NK cell function. This gene is a member of the NKG2 group of genes that are expressed primarily in natural killer (NK) cells. These family members encode transmembrane proteins that are characterized by a type II membrane orientation (have an extracellular C-terminus) and the presence of a C-type lectin domain. This family member is located within the NK complex, a region that contains several C-type lectin genes preferentially expressed in NK cells. Read-through transcription exists between this gene and the downstream KLRK1 (killer cell lectin-like receptor subfamily K, member 1) family member. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.9274346E-6).
BP6
Variant 12-10408358-T-C is Benign according to our data. Variant chr12-10408358-T-C is described in ClinVar as [Benign]. Clinvar id is 1273274.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.679 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KLRC4NM_013431.2 linkuse as main transcriptc.311A>G p.Asn104Ser missense_variant 3/4 ENST00000309384.3 NP_038459.1
KLRC4-KLRK1NM_001199805.1 linkuse as main transcriptc.-364A>G 5_prime_UTR_variant 3/13 NP_001186734.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KLRC4ENST00000309384.3 linkuse as main transcriptc.311A>G p.Asn104Ser missense_variant 3/41 NM_013431.2 ENSP00000310216 P1

Frequencies

GnomAD3 genomes
AF:
0.610
AC:
92590
AN:
151732
Hom.:
28918
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.471
Gnomad AMI
AF:
0.641
Gnomad AMR
AF:
0.670
Gnomad ASJ
AF:
0.598
Gnomad EAS
AF:
0.559
Gnomad SAS
AF:
0.550
Gnomad FIN
AF:
0.648
Gnomad MID
AF:
0.615
Gnomad NFE
AF:
0.684
Gnomad OTH
AF:
0.609
GnomAD3 exomes
AF:
0.628
AC:
148250
AN:
236222
Hom.:
47238
AF XY:
0.627
AC XY:
80408
AN XY:
128266
show subpopulations
Gnomad AFR exome
AF:
0.458
Gnomad AMR exome
AF:
0.638
Gnomad ASJ exome
AF:
0.595
Gnomad EAS exome
AF:
0.528
Gnomad SAS exome
AF:
0.551
Gnomad FIN exome
AF:
0.652
Gnomad NFE exome
AF:
0.680
Gnomad OTH exome
AF:
0.662
GnomAD4 exome
AF:
0.653
AC:
858921
AN:
1314668
Hom.:
284079
Cov.:
21
AF XY:
0.652
AC XY:
430251
AN XY:
660390
show subpopulations
Gnomad4 AFR exome
AF:
0.446
Gnomad4 AMR exome
AF:
0.646
Gnomad4 ASJ exome
AF:
0.594
Gnomad4 EAS exome
AF:
0.574
Gnomad4 SAS exome
AF:
0.550
Gnomad4 FIN exome
AF:
0.653
Gnomad4 NFE exome
AF:
0.675
Gnomad4 OTH exome
AF:
0.621
GnomAD4 genome
AF:
0.610
AC:
92657
AN:
151852
Hom.:
28937
Cov.:
31
AF XY:
0.608
AC XY:
45140
AN XY:
74202
show subpopulations
Gnomad4 AFR
AF:
0.471
Gnomad4 AMR
AF:
0.670
Gnomad4 ASJ
AF:
0.598
Gnomad4 EAS
AF:
0.559
Gnomad4 SAS
AF:
0.550
Gnomad4 FIN
AF:
0.648
Gnomad4 NFE
AF:
0.684
Gnomad4 OTH
AF:
0.612
Alfa
AF:
0.662
Hom.:
83022
Bravo
AF:
0.604
TwinsUK
AF:
0.687
AC:
2546
ALSPAC
AF:
0.688
AC:
2653
ESP6500AA
AF:
0.478
AC:
2102
ESP6500EA
AF:
0.679
AC:
5820
ExAC
AF:
0.628
AC:
76173
Asia WGS
AF:
0.562
AC:
1937
AN:
3442

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxAug 23, 2019This variant is associated with the following publications: (PMID: 23291587, 25203601) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.81
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
7.7
DANN
Benign
0.93
DEOGEN2
Benign
0.072
T
Eigen
Benign
-0.73
Eigen_PC
Benign
-0.81
FATHMM_MKL
Benign
0.067
N
LIST_S2
Benign
0.55
T
MetaRNN
Benign
0.0000039
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.3
L
MutationTaster
Benign
1.0
P
PrimateAI
Benign
0.26
T
PROVEAN
Uncertain
-2.8
D
REVEL
Benign
0.071
Sift
Benign
0.091
T
Sift4G
Benign
0.11
T
Polyphen
0.15
B
Vest4
0.014
MPC
0.27
ClinPred
0.0082
T
GERP RS
2.9
Varity_R
0.059
gMVP
0.068

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2617170; hg19: chr12-10560957; COSMIC: COSV58671646; COSMIC: COSV58671646; API